These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11750352)

  • 21. Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index.
    Hortal L; Fernández A; Losada A; Lorenzo M; Baamonde E; Plaza C; Gallego R; Vega N; Palop L
    Transplant Proc; 2001; 33(7-8):3110-1. PubMed ID: 11750337
    [No Abstract]   [Full Text] [Related]  

  • 22. High performance liquid chromatography cyclosporine monitoring: a predictor of renal graft outcome.
    Cicciarelli J; Avila D; Iwaki Y; Sather H; Mendez R
    Transplant Proc; 1998 Aug; 30(5):1683-4. PubMed ID: 9723243
    [No Abstract]   [Full Text] [Related]  

  • 23. Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function.
    Konstadinidou I; Boletis JN
    Transplant Proc; 2004 Mar; 36(2 Suppl):163S-166S. PubMed ID: 15041329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of cyclosporine therapy in kidney transplantation.
    Remuzzi G; Perico N; Gaspari F
    Transplant Proc; 1998 Aug; 30(5):1673-6. PubMed ID: 9723238
    [No Abstract]   [Full Text] [Related]  

  • 25. Polyclonal antilymphocyte sera induce immune activation in human renal allograft recipients.
    Book B; Pescovitz M; Leapman S; Filo R
    Transplant Proc; 1998 Jun; 30(4):1348-50. PubMed ID: 9636548
    [No Abstract]   [Full Text] [Related]  

  • 26. Abbreviated kinetic profiles to estimate exposure to CyA in renal allograft recipients treated with Sandimmun-Neoral.
    Serafinowicz A; Gaciong Z; Majchrzak J; Baczkowska T; Nowacka E; Gradowska L; Rowiński W; Lao M
    Transplant Proc; 1997; 29(1-2):277-9. PubMed ID: 9122994
    [No Abstract]   [Full Text] [Related]  

  • 27. Area under the curve of Neoral and chronic use of mycophenolate mofetil.
    Rial M; Guardia O; Greco G; Argento J; Casadei D
    Transplant Proc; 1998 Jun; 30(4):1195-6. PubMed ID: 9636484
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
    Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I
    Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral.
    Serafinowicz A; Gaciong Z; Baçzkowska T; Rell K; Lao M; Wałaszewski J
    Transplant Proc; 1996 Dec; 28(6):3138-9. PubMed ID: 8962216
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new strategy for monitoring levels of cyclosporin A in the blood of patients after kidney transplantation].
    Halacová M; Jedlicková B; Průsa R
    Ceska Slov Farm; 2003 Nov; 52(6):267-71. PubMed ID: 14661365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients.
    Citterio F; Scatà MC; Borzi MT; Pozzetto U; Castagneto M
    Transplant Proc; 2001; 33(7-8):3133-6. PubMed ID: 11750347
    [No Abstract]   [Full Text] [Related]  

  • 32. Post-OKT3 induction therapy CD complex response predicts renal allograft rejection.
    Stephan RN; Munschauer CE; Kohli RK; Sridhar NR; Hoover EL; Davidson IJ
    Transplantation; 1997 Apr; 63(8):1183-6. PubMed ID: 9133483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nomogram for predicting optimal dosage of cyclosporine in renal transplant patients: taking physiological factors into consideration for regimen during immunosuppressive therapy.
    Shibata N; Hoshino N; Minouchi T; Yamaji A
    Biol Pharm Bull; 1995 Oct; 18(10):1423-9. PubMed ID: 8593449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine lymphocyte versus whole blood pharmacokinetic monitoring: correlation with histological findings.
    Barbari A; Masri MA; Stephan A; Mokhbat J; Kilani H; Rizk S; Kamel G; Joubran N
    Transplant Proc; 2001 Aug; 33(5):2782-5. PubMed ID: 11498159
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients.
    Pozzetto U; Citterio F; Romagnoli J; Scatà M; Nanni G; Castagneto M
    Transplant Proc; 2002 Aug; 34(5):1740-2. PubMed ID: 12176558
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimization of cyclosporine exposure utilizing C(2) level monitoring in de novo renal transplant recipients: the Toronto General Hospital experience.
    Maham N; Cardella C; Cattran D; Fenton S; O'Grady C; Hamill J; Smith R; Cole E
    Transplant Proc; 2001; 33(7-8):3098-9. PubMed ID: 11750331
    [No Abstract]   [Full Text] [Related]  

  • 37. Greater variability of dose-corrected cyclosporine C2 concentrations in renal recipients with acute rejection.
    Chueh SC; Liao CH; Lai MK
    Transplant Proc; 2003 Feb; 35(1):234-5. PubMed ID: 12591378
    [No Abstract]   [Full Text] [Related]  

  • 38. Conversion of C-0 to C-2 monitoring of cyclosporine in stable kidney transplant patients.
    Jirasiritham S; Mavichak V; Danviriyasup K; Jirasiritham S
    Transplant Proc; 2003 Feb; 35(1):236-7. PubMed ID: 12591379
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant.
    Yang WC; Chen YF; King KL; Wu TH; Chen Hsu RY ; Tang JJ; Loong CC; Chou MH; Lin MF; Lui WY
    Transplant Proc; 2000 Nov; 32(7):1685-7. PubMed ID: 11119892
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies.
    Sommerer C; Konstandin M; Dengler T; Schmidt J; Meuer S; Zeier M; Giese T
    Transplantation; 2006 Nov; 82(10):1280-5. PubMed ID: 17130775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.